The Discounted Cash Flow (DCF) valuation of Neogenomics Inc (NEO) is (14.89) USD. With the latest stock price at 8.01 USD, the upside of Neogenomics Inc based on DCF is -286.0%.
Based on the latest price of 8.01 USD and our DCF valuation, Neogenomics Inc (NEO) is a sell. selling NEO stocks now will result in a potential gain of 286.0%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 6.3% - 9.3% | 7.8% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (38.38) - (10.12) | (14.89) |
| Upside | -579.2% - -226.4% | -286.0% |